The Gut-Heart Axis: Molecular Perspectives and Implications for Myocardial Infarction
dc.catalogador | gjm | |
dc.contributor.author | Rivera Vega, Katherine Solange | |
dc.contributor.author | Gonzalez, Leticia | |
dc.contributor.author | Bravo Urquiza, Liena Martina | |
dc.contributor.author | Manjarrés Madrid, Laura | |
dc.contributor.author | Andía Kohnenkampf, Marcelo Edgardo | |
dc.date.accessioned | 2025-03-06T18:56:37Z | |
dc.date.available | 2025-03-06T18:56:37Z | |
dc.date.issued | 2024 | |
dc.description.abstract | Myocardial infarction (MI) remains the leading cause of death globally, imposing a significant burden on healthcare systems and patients. The gut-heart axis, a bidirectional network connecting gut health to cardiovascular outcomes, has recently emerged as a critical factor in MI pathophysiology. Disruptions in this axis, including gut dysbiosis and compromised intestinal barrier integrity, lead to systemic inflammation driven by gut-derived metabolites like lipopolysaccharides (LPSs) and trimethylamine N-oxide (TMAO), both of which exacerbate MI progression. In contrast, metabolites such as short-chain fatty acids (SCFAs) from a balanced microbiota exhibit protective effects against cardiac damage. This review examines the molecular mediators of the gut-heart axis, considering the role of factors like sex-specific hormones, aging, diet, physical activity, and alcohol consumption on gut health and MI outcomes. Additionally, we highlight therapeutic approaches, including dietary interventions, personalized probiotics, and exercise regimens. Addressing the gut-heart axis holds promise for reducing MI risk and improving recovery, positioning it as a novel target in cardiovascular therapy. | |
dc.fechaingreso.objetodigital | 2025-03-06 | |
dc.format.extent | 25 páginas | |
dc.fuente.origen | WOS | |
dc.identifier.doi | 10.3390/ijms252212465 | |
dc.identifier.eissn | 1422-0067 | |
dc.identifier.issn | 1661-6596 | |
dc.identifier.uri | https://doi.org/10.3390/ijms252212465 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/102410 | |
dc.identifier.wosid | WOS:001365471100001 | |
dc.information.autoruc | Escuela de Medicina; Rivera Vega, Katherine Solange; S/I; 1063705 | |
dc.information.autoruc | Escuela de Medicina; Gonzalez, Leticia; S/I; 1061572 | |
dc.information.autoruc | Facultad de Ciencias Biológicas; Bravo Urquiza, Liena Martina; S/I; 1067812 | |
dc.information.autoruc | Escuela de Medicina; Manjarrés Madrid, Laura; S/I; 1183087 | |
dc.information.autoruc | Escuela de Medicina; Andía Kohnenkampf, Marcelo Edgardo; 0000-0002-1251-5832; 90691 | |
dc.issue.numero | 22 | |
dc.language.iso | en | |
dc.nota.acceso | contenido completo | |
dc.revista | International Journal of Molecular Sciences | |
dc.rights | acceso abierto | |
dc.rights.license | CC BY 4.0 Attribution 4.0 International | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.subject | Myocardial infarction | |
dc.subject | Gut-heart axis | |
dc.subject | Gut microbiota | |
dc.subject | Intestinal barrier | |
dc.subject | Gut metabolites | |
dc.subject.ddc | 610 | |
dc.subject.dewey | Medicina y salud | es_ES |
dc.subject.ods | 03 Good health and well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | The Gut-Heart Axis: Molecular Perspectives and Implications for Myocardial Infarction | |
dc.type | artículo de revisión | |
dc.volumen | 25 | |
sipa.codpersvinculados | 1063705 | |
sipa.codpersvinculados | 1061572 | |
sipa.codpersvinculados | 1067812 | |
sipa.codpersvinculados | 1183087 | |
sipa.codpersvinculados | 90691 | |
sipa.trazabilidad | WOS;2024-12-14 |
Files
Original bundle
1 - 1 of 1